Breaking Discovery: New Rare Genetic Disorder Identified – Causes, Symptoms, and Genetic Implications

Discovery of a New Rare Genetic Disorder

Researchers from Washington University School of Medicine, along with international collaborators, have identified a new rare genetic disorder that affects protein folding within cells. This breakthrough solved a decades-long medical mystery for a child with unexplained neurological symptoms.

Symptoms and Initial Findings

The German patient had intellectual disability, low muscle tone, and a small brain with abnormal structures. Brain scans revealed atypical features in the white matter and cerebellum.

Genetic Cause

The disorder is linked to changes in the CCT3 gene, which is part of the large TRIC/CCT molecular complex responsible for folding other proteins into their proper shape. The affected CCT3 protein reduces the activity of the normal protein, impacting the protein-folding machinery.

Research Methodology

To confirm the genetic cause, researchers used the tiny roundworm C. elegans, which has counterparts to about 50% of human genes, including CCT3. Studies showed that C. elegans with the patient’s genetic variant had reduced mobility and incorrectly folded actin proteins. Additional investigations in zebrafish and yeast further clarified the role of CCT3 in brain development and protein folding.

Implications for Treatment and Diagnosis

This discovery has significant implications for future treatments and diagnoses. The research identified 22 individuals with similar genetic changes in seven of the eight CCT proteins, representing a new type of rare genetic disease involving the protein folding machinery. Understanding the impact of these genetic changes informs treatment modalities, such as increasing the amount of normal protein.

Broader Impact

This work highlights the importance of using simpler model organisms like C. elegans to provide insights into human pathobiology. The findings can inform clinicians, the scientific community, and patients worldwide, enabling more accurate diagnoses and potential treatments for brain malformations and neurological symptoms.

Collaborative Efforts

The study was supported by the National Institute of Child Health and Human Development of the National Institutes of Health (NIH) and involved collaborations from over a dozen institutions across North America, Europe, India, and China. This global effort underscores the value of international cooperation in solving medical mysteries and advancing genetic research.